Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) delivered a lecture entitled "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation" before joining the round table discussion to interact with the attendees.

Hans Matter and Maria Méndez Pérez (Sanofi) delivered a lecture entitled "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors" before joining the round table discussion to interact with the attendees.

Fionn O'Hara and Bernd Kuhn (F. Hoffmann-La Roche) delivered a lecture on “Leveraging Structural Insights and Machine-learning Predictions for the Accelerated Optimization of Novel MAGL Inhibitors” before joining the round table discussion to interact with the attendees.

Taylor Quinn, Gail Wrigley & Alex Chinn (AstraZeneca) delivered a lecture on “Accelerated Discovery of a Carbamate Scaffold Cbl-b Inhibitor Using Generative Models and Structure-based Drug Design” before joining the round table discussion to interact with the attendees.

Ed Griffen & Jess Stacey (Medchemica Ltd) delivered a lecture on “Accelerating Lead Optimisation by Constantly Rebuilding Free Wilson Models Using Automated Core Finding in Anti-Viral Drug Discovery” before joining the round table discussion to interact with the attendees.

Judith Günther (Bayer) & Léa Bouché (Roche, former-Bayer) delivered a lecture on “BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe” before joining the round table discussion to interact with the attendees.

Sandra Handschuh & Theodor Theis (Boehringer Ingelheim) delivered a lecture on “Real World Use of FEP+ Calculations - Lessons Learned at Boehringer Ingelheim” before joining the round table discussion to interact with the attendees.